How the central domain of dystrophin acts to bridge F-actin to sarcolemmal lipids-Reference-Cited by-同舟云学术

How the central domain of dystrophin acts to bridge F-actin to sarcolemmal lipids

Published:2020-01 Issue:1 Volume:209 Page:107411
ISSN:1047-8477
Container-title:Journal of Structural Biology
language:en
Short-container-title:Journal of Structural Biology

Author:

Mias-Lucquin Dominique,Dos Santos Morais Raphael,Chéron Angélique,Lagarrigue Mélanie,Winder Steve J.,Chenuel Thomas,Pérez Javier,Appavou Marie-Sousai,Martel Anne,Alviset Guillaume,Le Rumeur Elisabeth,Combet Sophie,Hubert Jean-François,Delalande Olivier

Funder

AFM–Téléthon

Conseil Régional de Bretagne

Publisher

Elsevier BV

Subject

Structural Biology

Reference54 articles.

1. A cluster of basic repeats in the dystrophin rod domain binds F-actin through an electrostatic interaction;Amann;J. Biol. Chem.,1998

2. Utrophin lacks the rod domain actin binding activity of dystrophin;Amann;J. Biol. Chem.,1999

3. Personalized gene and cell therapy for Duchenne muscular dystrophy;Barthélémy;Neuromuscul. Disord.,2018

4. Microtubule binding distinguishes dystrophin from utrophin;Belanto;Proc. Natl. Acad. Sci. U.S.A,2014

5. Association of dystrophin and an integral membrane glycoprotein;Campbell;Nature,1989

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel CRISPR-Cas9 Strategy to Target DYSTROPHIN Mutations Downstream of Exon 44 in Patient-Specific DMD iPSCs;Cells;2024-06-04

2. Efficacy of exon-skipping therapy for DMD cardiomyopathy with mutations in actin binding domain 1;Molecular Therapy - Nucleic Acids;2023-12

3. Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review;BioDrugs;2023-11-02

4. Therapeutic Strategies for Dystrophin Replacement in Duchenne Muscular Dystrophy;Frontiers in Medicine;2022-03-28

5. CRISPR-Cas9 Gene Therapy for Duchenne Muscular Dystrophy;Neurotherapeutics;2022-02-14